2,255
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Therapeutic ultrasound treatment for the prevention of chronic kidney disease-associated muscle wasting in mice

, , , , ORCID Icon, & ORCID Icon show all
Pages 268-275 | Received 31 Jan 2023, Accepted 08 May 2023, Published online: 17 May 2023

References

  • Kovesdy CP. Epidemiology of chronic kidney disease: an update 2022. Kidney Int Suppl (2011). 2022;12(1):7–11.
  • United States Renal Database System (USRDS). 2022. Annual Data Report, Chronic Kidney Disease: Chapter 1. https://usrds-adr.niddk.nih.gov/2022/chronic-kidney-disease/1-ckd-in-the-general-population.
  • Koppe L, Fouque D, Kalantar-Zadeh K. Kidney cachexia or protein-energy wasting in chronic kidney disease: facts and numbers. J Cachexia Sarcopenia Muscle. 2019;10(3):479–484.
  • Cianciaruso B, Brunori G, Kopple JD, et al. Cross-sectional comparison of malnutrition in continuous ambulatory peritoneal dialysis and hemodialysis patients. Am J Kidney Dis. 1995;26(3):475–486.
  • Bataille S, Serveaux M, Carreno E, et al. The diagnosis of sarcopenia is mainly driven by muscle mass in hemodialysis patients. Clin Nutr. 2017;36(6):1654–1660.
  • Kim JK, Choi SR, Choi MJ, et al. Prevalence of and factors associated with sarcopenia in elderly patients with end-stage renal disease. Clin Nutr. 2014;33(1):64–68.
  • Stenvinkel P, Carrero JJ, von Walden F, et al. Muscle wasting in end-stage renal disease promulgates premature death: established, emerging and potential novel treatment strategies. Nephrol Dial Transplant. 2016;31(7):1070–1077.
  • Zhang Y, Liu Y, Bi X, et al. Therapeutic approaches in mitochondrial dysfunction, inflammation, and autophagy in uremic cachexia: role of aerobic exercise. Mediators Inflamm. 2019;2019:2789014.
  • Palanisamy P, Alam M, Li S, et al. Low-intensity pulsed ultrasound stimulation for bone fractures healing: a review. J Ultrasound Med. 2022;41(3):547–563.
  • Ogata T, Ito K, Shindo T, et al. Low-intensity pulsed ultrasound enhances angiogenesis and ameliorates contractile dysfunction of pressure-overloaded heart in mice. PLoS One. 2017;12(9):e0185555.
  • Tang L, Li N, Jian W, et al. Low-intensity pulsed ultrasound prevents muscle atrophy induced by type 1 diabetes in rats. Skelet Muscle. 2017;7(1):29.
  • Lin CY, Wang CC, Loh JZ, et al. Therapeutic ultrasound halts progression of chronic kidney disease in vivo via the regulation of markers associated with renal epithelial-mesenchymal transition and senescence. IJMS. 2022;23(21):13387.
  • Shu S, Zhu J, Liu Z, et al. Endoplasmic reticulum stress is activated in post-ischemic kidneys to promote chronic kidney disease. EBioMedicine. 2018;37:269–280.
  • Webster AC, Nagler EV, Morton RL, et al. Chronic kidney disease. Lancet. 2017;389(10075):1238–1252.
  • Chiang CK, Loh JZ, Yang TH, et al. Prevention of acute kidney injury by low intensity pulsed ultrasound via anti-inflammation and anti-apoptosis. Sci Rep. 2020;10(1):14317.
  • Chiu HC, Chiu CY, Yang RS, et al. Preventing muscle wasting by osteoporosis drug alendronate in vitro and in myopathy models via sirtuin-3 down-regulation. J Cachexia Sarcopenia Muscle. 2018;9(3):585–602.
  • Xin Z, Lin G, Lei H, et al. Clinical applications of low-intensity pulsed ultrasound and its potential role in urology. Transl Androl Urol. 2016;5(2):255–266.
  • Mak RH, Ikizler AT, Kovesdy CP, et al. Wasting in chronic kidney disease. J Cachexia Sarcopenia Muscle. 2011;2(1):9–25.
  • Tsuruta JK, Dayton PA, Gallippi CM, et al. Therapeutic ultrasound as a potential male contraceptive: power, frequency and temperature required to deplete rat testes of meiotic cells and epididymides of sperm determined using a commercially available system. Reprod Biol Endocrinol. 2012;10:7.
  • Brightwell CR, Kulkarni AS, Paredes W, et al. Muscle fibrosis and maladaptation occur progressively in CKD and are rescued by dialysis. JCI Insight. 2021;6(24):e150112.
  • Dong J, Dong Y, Chen Z, et al. The pathway to muscle fibrosis depends on myostatin stimulating the differentiation of fibro/adipogenic progenitor cells in chronic kidney disease. Kidney Int. 2017;91(1):119–128.
  • Holecek M. Muscle wasting in animal models of severe illness. Int J Exp Pathol. 2012;93(3):157–171.
  • Sirago G, Picca A, Calvani R, et al. Mammalian target of rapamycin (mTOR) signaling at the crossroad of muscle fiber fate in sarcopenia. IJMS. 2022;23(22):13823.
  • Sasako T, Umehara T, Soeda K, et al. Deletion of skeletal muscle Akt1/2 causes osteosarcopenia and reduces lifespan in mice. Nat Commun. 2022;13(1):5655.
  • Jaiswal N, Gavin M, Loro E, et al. AKT controls protein synthesis and oxidative metabolism via combined mTORC1 and FOXO1 signalling to govern muscle physiology. J Cachexia Sarcopenia Muscle. 2022;13(1):495–514.
  • Molina P, Carrero JJ, Bover J, et al. Vitamin D, a modulator of musculoskeletal health in chronic kidney disease. J Cachexia Sarcopenia Muscle. 2017;8(5):686–701.
  • Enoki Y, Watanabe H, Arake R, et al. Potential therapeutic interventions for chronic kidney disease-associated sarcopenia via indoxyl sulfate-induced mitochondrial dysfunction. J Cachexia Sarcopenia Muscle. 2017;8(5):735–747.
  • Cheng TC, Huang SH, Kao CL, et al. Muscle wasting in chronic kidney disease: mechanism and clinical implications-A narrative review. IJMS. 2022;23(11):6047.
  • Schardong J, Dipp T, Bozzeto CB, et al. Effects of intradialytic neuromuscular electrical stimulation on strength and muscle architecture in patients with chronic kidney failure: randomized clinical trial. Artif Organs. 2017;41(11):1049–1058.
  • Schardong J, Falster M, Sisto IR, et al. Photobiomodulation therapy increases functional capacity of patients with chronic kidney failure: randomized controlled trial. Lasers Med Sci. 2021;36(1):119–129.
  • Cho YS, Joo SY, Lee EK, et al. Effect of extracorporeal shock wave therapy on muscle mass and function in patients undergoing maintenance hemodialysis: a randomized controlled pilot study. Ultrasound Med Biol. 2021;47(11):3202–3210.